Laguna Biotherapeutics, Inc. (Laguna), a biotechnology company focused on novel live bacterial therapeutics, today announced its upcoming schedule of scientific presentations and keynote speaking engagements for 2025. Throughout the year, company leadership will present preclinical data, discuss platform developments, and share insights on building frontier biotechnology companies across top-tier scientific congresses and industry forums.
The upcoming presentation and event schedule includes:
American Association for Cancer Research (AACR) Annual Meeting
Date: April 27, 2025
Location: McCormick Place Convention Center, Chicago, IL
Format: Poster Presentation
Overview: Jonathan Kotula, Ph.D., CEO and co-founder of Laguna, will present preclinical data highlighting the company's therapeutic platform and mechanism of action.
γδ T Cell Conference
Date: May 22, 2025
Location: Hilton Toronto Downtown, Toronto, Canada
Format: Poster Presentation
Overview: Jonathan Kotula, Ph.D., CEO and co-founder of Laguna, will present poster findings focusing on the targeted activation and expansion of endogenous γδ T cells.
The Engine’s Tough Tech Summit
Date: October 28, 2025
Location: Hotel Commonwealth, Boston, MA
Format: Invited Presentation
Overview: Jonathan Kotula, Ph.D., CEO and co-founder of Laguna, will deliver a talk outlining the translational engineering required to convert a microbial pathogen into a transformative, novel class of immunotherapy.
Life & Medical Sciences Institute (LIMES) – University of Bonn
Date: December 10, 2025
Location: University of Bonn, Bonn, Germany
Format: Invited Speaker Series
Overview: Jonathan Kotula, Ph.D., Laguna’s CEO and co-founder, will present on the process of translating scientific breakthroughs from research labs into scalable biotech ventures.
"2025 is a critical year of momentum for Laguna as we continue to generate impactful data and broaden our reach across both the scientific and venture communities," said Jonathan Kotula, Ph.D., CEO and co-founder of Laguna. "From showcasing our mechanism of action at premier cancer research meetings like AACR to sharing our playbook for building tough tech companies at LIMES and The Engine, we are eager to engage with academic collaborators, industry peers, and strategic partners worldwide."
About Laguna Biotherapeutics, Inc. (Laguna)
Laguna is a privately funded, IND-stage biotechnology company headquartered in San Francisco, CA with research labs in Siena, Italy. It is focused on developing novel therapeutics that activate and expand the immune system to create impactful treatments across oncology, as well as inflammatory and infectious diseases.
